Pharmaceutical companies can't find patients for trials of experimental cancer drugs Dr. Peter Bach Too few patients are available to cover all the clinical cancer drug trials being conducted. That, at least, is the conclusion of a recent story by Gina Kolata in The...
Smaller studies can mean missed side effects
read more